Migraines are often linked to increased activity of calcitonin gene-related peptide (CGRP), a signaling molecule known to trigger pain sensitivity, light sensitivity, and other migraine symptoms. In this preclinical study, researchers examined whether a combination of cannabidiol (CBD) and tetrahydrocannabinol (THC) could reduce migraine-like symptoms caused by central CGRP administration in mice. Scientists used established […]